Medication info
Lozaka Tablet (Losartan Potassium)

Lozaka Tablet (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Genupha Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200501119 · Notified 2005.08.10 · Insurance code 698000720

Summary

Main use
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but taking it at the same time each day is recommended. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be given orally in 2 divided doses daily, or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered with insulin and commonly used antidiabetic medicines (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special populations 1) Older adults No adjustment of the initial dose is necessary in older adults 75 years or younger. For older adults over 75 years, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced intravascular effective circulating volume An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced intravascular effective circulating volume (e.g., patients receiving diuretics) (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
2) Children and adolescents 6 years and older (1) Patients weighing 20 kg or more but less than 50 kg who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily; the dose may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; the dose may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. (3) Children under 6 years: Not recommended. (3) Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. (3) Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Genupha Co., Ltd.

Efficacy & effects

Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used for the treatment of hypertension and helps prevent and manage kidney disease in patients with type 2 diabetes. It is effective in reducing complications caused by hypertension and protecting kidney function. Therefore, it is used to improve hypertension and related kidney diseases.

How to take

Adult dose

This medicine may be taken with or without food, but taking it at the same time each day is recommended. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be given orally in 2 divided doses daily, or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered with insulin and commonly used antidiabetic medicines (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special populations 1) Older adults No adjustment of the initial dose is necessary in older adults 75 years or younger. For older adults over 75 years, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced intravascular effective circulating volume An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced intravascular effective circulating volume (e.g., patients receiving diuretics) (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

2) Children and adolescents 6 years and older (1) Patients weighing 20 kg or more but less than 50 kg who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily; the dose may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; the dose may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. (3) Children under 6 years: Not recommended. (3) Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. (3) Pediatric patients with hepatic impairment: Not recommended.

Precautions

This drug can cause serious harm to the fetus, especially when taken during the second and third trimesters of pregnancy; therefore, women who are pregnant or may become pregnant should not take this medication. If pregnancy is confirmed, the use of this medication should be discontinued as soon as possible. This medication should not be administered to patients with severe liver dysfunction or certain genetic diseases, and caution is required for patients with a history of angioedema. Elderly patients or those with decreased kidney function, and patients with hyperkalemia should use this medication cautiously and should be monitored to ensure that blood pressure does not drop too low. During the use of this medication, it is important to regularly check blood pressure, kidney function, and blood potassium levels to ensure there are no abnormalities. Additionally, this medication can increase blood potassium levels to dangerous levels when taken with certain diuretics or potassium supplements, so such medications should not be taken without consulting a doctor. This medication may rarely cause side effects such as angioedema, liver function abnormalities, muscle pain, low blood pressure, and renal failure, so if symptoms appear, immediate notification to medical personnel is required. Persistent cough may occur, but it is relatively less common compared to other antihypertensive medications. Moreover, this medication is not recommended for breastfeeding women; if breastfeeding, the drug should be avoided or breastfeeding should be discontinued. It is advisable to avoid grapefruit juice while taking this medication, and since there may be interactions with other medications, one should consult medical personnel regarding all medications being taken. Lastly, keep this medication out of the reach of children, and be careful not to transfer it into other containers.

Side effects

  • Craniosynostosis
  • Anuria
  • Hypotension
  • Renal failure
  • Death
  • Muscle cramps
  • Back pain
  • Leg pain
  • Dizziness
  • Congestion
Show 118 more
  • Upper respiratory infection
  • Sinusitis
  • Nausea
  • Diarrhea
  • Indigestion
  • Cough
  • Sinus disturbances
  • Pharyngitis
  • Myalgia
  • Insomnia
  • Headache
  • Weakness/Fatigue
  • Edema/Swelling
  • Abdominal pain
  • Chest pain
  • Lip swelling
  • Eyelid swelling
  • Facial rash
  • Palm skin peeling
  • Hemolysis
  • Facial swelling
  • Fever
  • Orthostatic effects
  • Syncope
  • Angina
  • Second-degree atrioventricular block
  • Cerebrovascular accident
  • Myocardial infarction
  • Atrial fibrillation
  • Palpitations
  • Bradycardia
  • Tachycardia
  • Ventricular tachycardia
  • Ventricular fibrillation
  • Anorexia
  • Constipation
  • Toothache
  • Dry mouth
  • Flatulence
  • Gastritis
  • Vomiting
  • Anemia
  • Gout
  • Upper limb pain
  • Hip pain
  • Joint swelling
  • Knee pain
  • Muscle weakness
  • Arthralgia
  • Arthritis
  • Fibromyalgia
  • Anxiety
  • Anxiety disorder
  • Ataxia
  • Confusion
  • Depression
  • Nightmares
  • Sensory loss
  • Decreased libido
  • Memory impairment
  • Migraine
  • Neurodermatitis
  • Sensory abnormalities
  • Peripheral neuropathy
  • Panic disorder
  • Sleep disorder
  • Hypersomnia
  • Tremor
  • Dyspnea
  • Bronchitis
  • Pharyngeal discomfort
  • Epistaxis
  • Rhinitis
  • Respiratory congestion
  • Chest discomfort
  • Hair loss
  • Dermatitis
  • Dry skin
  • Petechiae
  • Erythema
  • Flushing
  • Photosensitivity reaction
  • Itching
  • Rash
  • Sweating
  • Urticaria
  • Blurred vision
  • Eye burning and pain
  • Conjunctivitis
  • Dysgeusia
  • Tinnitus
  • Vision loss
  • Erectile dysfunction
  • Nocturia
  • Frequent urination
  • Urethral infection
  • Angioedema
  • Vasculitis
  • Anaphylactoid syndrome
  • Liver dysfunction
  • Hepatitis
  • Intestinal vascular edema
  • Lethargy
  • Thrombocytopenia
  • Elevated creatine kinase
  • Rhabdomyolysis
  • Acute renal failure
  • Dry cough
  • Erythema nodosum
  • Hyponatremia
  • Elevated ALT
  • Syncope
  • Loss of consciousness
  • Acute hepatitis
  • Fulminant hepatitis
  • Ventricular extrasystole
  • Arrhythmia
  • Hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is also important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the drug for a longer period.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.